Abstract
The genetic susceptibility to malignant hyperthermia (MH) results from variants in the RYR1 and CACNA1S genes. The majority (48) of these diagnostic variants are in RYR1, with only two in CACNA1S. We have previously identified the novel CACNA1S variant c.3026C>A (p.T1009K) as potentially pathogenic for MH,1,2 but it has not yet been functionally characterised. We have thus generated a knock-in mouse line expressing the isogenic mutation p.T1009K, and we investigated whether it has an MH phenotype.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
